Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort

by Koegl, C, Wolf, E, Hanhoff, N, Jessen, H, Schewe, K, Rausch, M, Goelz, J, Goetzenich, A, Knechten, H, Jaeger, H
Published 2009

A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected...

by Ulbricht, K.U, Behrens, G.M, Stoll, M, Salzberger, B, Jessen, H, Jessen, A.B, Kuhlmann, B, Heiken, H, Trein, A, Schmidt, R.E
Published 2011

HIV-specific cytolytic CD4 T-cell responses effectively control HIV infection in macrophages

by Soghoian, DZ, Flanders, M, Sierra-Davidson, K, Ranasinghe, S, Cutler, S, Davis, I, Lindqvist, M, Lane, K, Kuhl, B, Kranias, G, Piechocka-Trocha, A, Jessen, H, Walker, BD, Streeck, H
Published 2012